Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 3234634)

Published in Diabetologia on November 01, 1988

Authors

L O Ohlson1, B Larsson, P Björntorp, H Eriksson, K Svärdsudd, L Welin, G Tibblin, L Wilhelmsen

Author Affiliations

1: Gothenburg University, Section for Preventive Medicine, Sweden.

Articles citing this

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65

Association between serum uric acid and development of type 2 diabetes. Diabetes Care (2009) 2.49

Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ (1995) 2.31

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care (2009) 2.23

The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53

Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45

Plasma copeptin and the risk of diabetes mellitus. Circulation (2010) 1.44

Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol (2010) 1.26

Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes. Pflugers Arch (2009) 1.17

Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol (2009) 1.15

Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and whole-body lipolysis in healthy young male offspring of patients with type 2 diabetes. Diabetes (2009) 1.09

Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res (2010) 1.02

L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats. Free Radic Biol Med (2009) 1.01

Short-term weight change and fluctuation as risk factors for type 2 diabetes in Finnish male smokers. Eur J Epidemiol (2010) 0.94

Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol (2009) 0.93

Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes. Diabetologia (2008) 0.92

Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia (2010) 0.91

Effects of diabetes family history and exercise training on the expression of adiponectin and leptin and their receptors. Metabolism (2010) 0.87

Plasma bicarbonate and risk of type 2 diabetes mellitus. CMAJ (2012) 0.87

Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study. PLoS One (2013) 0.85

Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transport. Biomed Res Int (2014) 0.84

The association between liver enzymes and risk of type 2 diabetes: the Namwon study. Diabetol Metab Syndr (2014) 0.83

Accurate body composition measures from whole-body silhouettes. Med Phys (2015) 0.83

Evaluation of Beneficial Metabolic Effects of Berries in High-Fat Fed C57BL/6J Mice. J Nutr Metab (2014) 0.81

Plasma Lactate Levels Increase during Hyperinsulinemic Euglycemic Clamp and Oral Glucose Tolerance Test. J Diabetes Res (2015) 0.78

Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study. Ann Epidemiol (2013) 0.77

Choline supplementation alters some amino acid concentrations with no change in homocysteine in children with cystic fibrosis and pancreatic insufficiency. Nutr Res (2015) 0.77

Oxamate Improves Glycemic Control and Insulin Sensitivity via Inhibition of Tissue Lactate Production in db/db Mice. PLoS One (2016) 0.77

Type 2 diabetes exaggerates exercise effort and impairs exercise performance in older women. BMJ Open Diabetes Res Care (2015) 0.75

Risks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workers. Ann Occup Environ Med (2016) 0.75

Lactate, a Neglected Factor for Diabetes and Cancer Interaction. Mediators Inflamm (2016) 0.75

Combined genome-wide linkage and association analyses of fasting glucose level in healthy twins and families of Korea. J Korean Med Sci (2013) 0.75

Influence of a home-based exercise program on the urine pH in elderly female subjects: a secondary analysis of a randomized controlled trial. Eur Rev Aging Phys Act (2017) 0.75

Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats with a SGLT2 Inhibitor Restores Glucose Effectiveness in Liver and Reduces Insulin Resistance in Skeletal Muscle. Diabetes (2017) 0.75

Articles by these authors

Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79

PROTEGE-II: computer support for development of intelligent systems from libraries of components. Medinfo (1995) 5.71

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) (1984) 5.06

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70

Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet (1974) 4.40

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23

Ontology-based configuration of problem-solving methods and generation of knowledge-acquisition tools: application of PROTEGE-II to protocol-based decision support. Artif Intell Med (1995) 3.99

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78

Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab (1998) 3.75

Smoking and myocardial infarction. Lancet (1975) 3.42

Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol (1999) 3.35

Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15

Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89

Bias due to non-participation and heterogenous sub-groups in population surveys. J Chronic Dis (1983) 2.62

Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57

The epidemiologic evidence for a relationship between social support and health. Am J Epidemiol (1983) 2.46

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab (1997) 2.31

Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26

The study of women in Gothenburg 1968-1969--a population study. General design, purpose and sampling results. Acta Med Scand (1973) 2.26

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23

The health consequences of moderate obesity. Int J Obes (1981) 2.21

Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20

Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16

A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand (1965) 2.16

The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med (2000) 2.14

Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08

Sick-listing habits among general practitioners in a Swedish county. Scand J Prim Health Care (2000) 1.99

Androgen treatment of abdominally obese men. Obes Res (1993) 1.99

Pre-operative fasting guidelines: an update. Acta Anaesthesiol Scand (2005) 1.94

Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol (1975) 1.94

A primary preventive study of Gothenburg, Sweden. Prev Med (1972) 1.92

Prevalence of subjectively experienced symptoms in a population sample of women with special reference to women with arterial hypertension. Scand J Prim Health Care (1987) 1.90

Effect of patients' expectations on recovery from acute tonsillitis. Fam Pract (1989) 1.90

Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90

The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85

A new concept for isokinetic hamstring: quadriceps muscle strength ratio. Am J Sports Med (1998) 1.85

Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84

Increased mortality among sleepy snorers: a prospective population based study. Thorax (1998) 1.82

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med (2000) 1.81

Sjöström L,+SJOSTROM L: Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism (1971) 1.80

A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis (1976) 1.80

Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J Lipid Res (1971) 1.79

Testosterone concentrations in women and men with NIDDM. Diabetes Care (1994) 1.78

Mortality associated with body fat, fat-free mass and body mass index among 60-year-old swedish men-a 22-year follow-up. The study of men born in 1913. Int J Obes Relat Metab Disord (2000) 1.78

Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76

Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med (1973) 1.76

Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother (2001) 1.76

Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Göteborg. Ann Epidemiol (1997) 1.75